Annual Net Income
-$25.26 M
+$9.67 M+27.68%
December 31, 2023
Summary
- As of February 7, 2025, PBLA annual net profit is -$25.26 million, with the most recent change of +$9.67 million (+27.68%) on December 31, 2023.
- During the last 3 years, PBLA annual net income has fallen by -$20.50 million (-429.84%).
- PBLA annual net income is now -10311.40% below its all-time high of $247.40 thousand, reached on December 31, 2012.
Performance
PBLA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$7.17 M
-$33.00 K-0.46%
September 30, 2024
Summary
- As of February 7, 2025, PBLA quarterly net profit is -$7.17 million, with the most recent change of -$33.00 thousand (-0.46%) on September 30, 2024.
- Over the past year, PBLA quarterly net income has dropped by -$698.00 thousand (-10.78%).
- PBLA quarterly net income is now -6304.15% below its all-time high of $115.60 thousand, reached on December 31, 2012.
Performance
PBLA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$27.91 M
+$659.00 K+2.31%
September 30, 2024
Summary
- As of February 7, 2025, PBLA TTM net profit is -$27.91 million, with the most recent change of +$659.00 thousand (+2.31%) on September 30, 2024.
- Over the past year, PBLA TTM net income has dropped by -$2.65 million (-10.51%).
- PBLA TTM net income is now -11379.30% below its all-time high of $247.40 thousand, reached on December 31, 2012.
Performance
PBLA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
PBLA Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.7% | -10.8% | -10.5% |
| 3 y3 years | -429.8% | -40.3% | +23.3% |
| 5 y5 years | -327.8% | -40.3% | +23.3% |
PBLA Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -149.3% | +27.7% | -102.7% | +67.6% | -175.7% | +23.3% |
| 5 y | 5-year | -429.8% | +27.7% | -1611.7% | +67.6% | -511.3% | +23.3% |
| alltime | all time | <-9999.0% | +27.7% | -6304.1% | +67.6% | <-9999.0% | +23.3% |
Panbela Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.17 M(+0.5%) | -$27.91 M(-2.3%) |
| Jun 2024 | - | -$7.14 M(+0.3%) | -$28.56 M(+4.8%) |
| Mar 2024 | - | -$7.12 M(+10.0%) | -$27.26 M(+7.9%) |
| Dec 2023 | -$25.26 M(-27.7%) | -$6.47 M(-17.3%) | -$25.25 M(+7.4%) |
| Sep 2023 | - | -$7.83 M(+34.3%) | -$23.51 M(+17.1%) |
| Jun 2023 | - | -$5.83 M(+14.1%) | -$20.08 M(-44.8%) |
| Mar 2023 | - | -$5.11 M(+8.0%) | -$36.38 M(+4.1%) |
| Dec 2022 | -$34.93 M(+244.7%) | -$4.74 M(+7.6%) | -$34.93 M(+3.5%) |
| Sep 2022 | - | -$4.40 M(-80.1%) | -$33.74 M(+7.2%) |
| Jun 2022 | - | -$22.13 M(+503.7%) | -$31.48 M(+172.9%) |
| Mar 2022 | - | -$3.67 M(+3.6%) | -$11.53 M(+13.9%) |
| Dec 2021 | -$10.13 M(+112.6%) | -$3.54 M(+65.2%) | -$10.12 M(+35.6%) |
| Sep 2021 | - | -$2.14 M(-2.0%) | -$7.46 M(+6.7%) |
| Jun 2021 | - | -$2.19 M(-3.1%) | -$6.99 M(+33.8%) |
| Mar 2021 | - | -$2.26 M(+156.5%) | -$5.23 M(+9.6%) |
| Dec 2020 | -$4.77 M(-23.1%) | -$880.00 K(-47.3%) | -$4.77 M(-1.9%) |
| Sep 2020 | - | -$1.67 M(+298.8%) | -$4.86 M(+6.5%) |
| Jun 2020 | - | -$419.00 K(-76.7%) | -$4.57 M(-28.9%) |
| Mar 2020 | - | -$1.80 M(+84.6%) | -$6.42 M(+3.5%) |
| Dec 2019 | -$6.20 M(+5.0%) | -$974.00 K(-29.1%) | -$6.20 M(+3.9%) |
| Sep 2019 | - | -$1.37 M(-39.5%) | -$5.97 M(+8.1%) |
| Jun 2019 | - | -$2.27 M(+43.6%) | -$5.52 M(-3.7%) |
| Mar 2019 | - | -$1.58 M(+113.6%) | -$5.73 M(-2.9%) |
| Dec 2018 | -$5.91 M | -$740.00 K(-20.0%) | -$5.90 M(-19.4%) |
| Sep 2018 | - | -$925.00 K(-62.8%) | -$7.32 M(-3.9%) |
| Jun 2018 | - | -$2.48 M(+41.8%) | -$7.62 M(+16.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$1.75 M(-18.9%) | -$6.55 M(-36.8%) |
| Dec 2017 | -$10.37 M(+102.9%) | -$2.16 M(+77.3%) | -$10.37 M(-0.7%) |
| Sep 2017 | - | -$1.22 M(-13.8%) | -$10.44 M(+1.4%) |
| Jun 2017 | - | -$1.41 M(-74.6%) | -$10.30 M(+4.4%) |
| Mar 2017 | - | -$5.57 M(+149.0%) | -$9.87 M(+92.8%) |
| Dec 2016 | -$5.11 M(+3.8%) | -$2.24 M(+107.4%) | -$5.12 M(+41.8%) |
| Sep 2016 | - | -$1.08 M(+10.3%) | -$3.61 M(+8.6%) |
| Jun 2016 | - | -$978.00 K(+18.7%) | -$3.32 M(-6.7%) |
| Mar 2016 | - | -$824.00 K(+13.2%) | -$3.56 M(-27.7%) |
| Dec 2015 | -$4.93 M(+39.5%) | -$728.00 K(-8.2%) | -$4.93 M(-4.8%) |
| Sep 2015 | - | -$793.00 K(-34.7%) | -$5.17 M(-6.4%) |
| Jun 2015 | - | -$1.22 M(-44.5%) | -$5.53 M(+26.5%) |
| Mar 2015 | - | -$2.19 M(+124.5%) | -$4.37 M(+90.9%) |
| Dec 2014 | -$3.53 M(+1565.6%) | -$976.00 K(-14.7%) | -$2.29 M(+71.8%) |
| Sep 2014 | - | -$1.14 M(+1896.5%) | -$1.33 M(+441.0%) |
| Jun 2014 | - | -$57.30 K(-48.2%) | -$246.20 K(+3.6%) |
| Mar 2014 | - | -$110.60 K(+450.2%) | -$237.70 K(+15.3%) |
| Dec 2013 | -$212.00 K(-185.7%) | -$20.10 K(-65.5%) | -$206.20 K(+192.5%) |
| Sep 2013 | - | -$58.20 K(+19.3%) | -$70.50 K(-215.0%) |
| Jun 2013 | - | -$48.80 K(-38.3%) | $61.30 K(-69.7%) |
| Mar 2013 | - | -$79.10 K(-168.4%) | $202.30 K(-18.2%) |
| Dec 2012 | $247.40 K(-278.9%) | $115.60 K(+57.1%) | $247.40 K(+87.7%) |
| Sep 2012 | - | $73.60 K(-20.2%) | $131.80 K(+126.5%) |
| Jun 2012 | - | $92.20 K(-371.2%) | $58.20 K(-271.2%) |
| Mar 2012 | - | -$34.00 K | -$34.00 K |
| Dec 2011 | -$138.30 K | - | - |
FAQ
- What is Panbela Therapeutics annual net profit?
- What is the all time high annual net income for Panbela Therapeutics?
- What is Panbela Therapeutics annual net income year-on-year change?
- What is Panbela Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly net income year-on-year change?
- What is Panbela Therapeutics TTM net profit?
- What is the all time high TTM net income for Panbela Therapeutics?
- What is Panbela Therapeutics TTM net income year-on-year change?
What is Panbela Therapeutics annual net profit?
The current annual net income of PBLA is -$25.26 M
What is the all time high annual net income for Panbela Therapeutics?
Panbela Therapeutics all-time high annual net profit is $247.40 K
What is Panbela Therapeutics annual net income year-on-year change?
Over the past year, PBLA annual net profit has changed by +$9.67 M (+27.68%)
What is Panbela Therapeutics quarterly net profit?
The current quarterly net income of PBLA is -$7.17 M
What is the all time high quarterly net income for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly net profit is $115.60 K
What is Panbela Therapeutics quarterly net income year-on-year change?
Over the past year, PBLA quarterly net profit has changed by -$698.00 K (-10.78%)
What is Panbela Therapeutics TTM net profit?
The current TTM net income of PBLA is -$27.91 M
What is the all time high TTM net income for Panbela Therapeutics?
Panbela Therapeutics all-time high TTM net profit is $247.40 K
What is Panbela Therapeutics TTM net income year-on-year change?
Over the past year, PBLA TTM net profit has changed by -$2.65 M (-10.51%)